Global Biosimilar Monoclonal Antibodies Industry Outlook 2022: Overview, Opportunities, Key Companies and Forecast to 2028

Published on: 2022-01-21 | No of Pages : 323 | Industry : Pharma & Healthcare

Publisher : GRD Survey | Format : PDF

Global Biosimilar Monoclonal Antibodies Industry Outlook 2022: Overview, Opportunities, Key Companies and Forecast to 2028

Executive Summary

According to GRD Survey data, the global Biosimilar Monoclonal Antibodies market is estimated at 4950 million US$ in 2021 and is expected to reach 47200 million US$ by the end of 2028, growing at a CAGR of 38.0% in the forecast period between 2022 and 2028.

This report studies the Biosimilar Monoclonal Antibodies market dynamics from angles such as new entries, mergers and acquisitions, fundings, exit and major technology breakthroughs. Market performance is evaluated through market size (value and volume) by players, regions, product types and end industries. This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Biosimilar Monoclonal Antibodies in these regions, from 2016 to 2027, covering
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Italy, Spain and Russia, etc.)
Asia-Pacific (China, Japan, Korea, Southeast Asia, India, Australia)
South America (Brazil, Argentina, Colombia, etc.)
Middle East and Africa (Turkey, Saudi Arabia, South Africa, etc.)

Market Snapshot, By Product Type
Infliximab
Rituximab
Trastuzumab
Adalimumab
Other

Market Snapshot, By Application
Oncology
Autoimmune Disease
Other

Main Market Players Analyzed in this report, including:
Torrent Pharmaceuticals
Pfizer (Hospira)
Novartis (Sandoz)
Hisun Pharma
Dr Reddy’s
Celltrion
Celgen Biopharma
Cadila Healthcare
3SBIO

The study objectives of this report are:
To study and analyze the global Biosimilar Monoclonal Antibodies market size (value & volume) by company, key regions/countries, products and application, history data from 2016 to 2020, and forecast to 2027.
To understand industry structure of Biosimilar Monoclonal Antibodies market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To identify the key global Biosimilar Monoclonal Antibodies manufacturers and regional typical players, to define, describe and analyze their sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Biosimilar Monoclonal Antibodies market with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Biosimilar Monoclonal Antibodies submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Biosimilar Monoclonal Antibodies are as follows:
History Year: 2016-2020
Base Year: 2020
Estimated Year: 2021
Forecast Year 2021 to 2027

This report includes the estimation of market size in terms of value (million USD) and volume from top-down approach by analyzing major submarkets and their major driving factors, and verified from bottom-up approaches. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified from primary sources.

For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders Considered in the study:
Raw material vendors
Distributors/traders/wholesalers/suppliers
Regulatory authorities, including government agencies and NGO
Commercial research & development (R&D) institutions
Importers and exporters
Government organizations, research organizations, and consulting firms
Trade/Industrial associations
End-use industries

Table of Content

Table of Contents

1 Market Definition & Scope
1.1 Definition & Scope
1.2 Biosimilar Monoclonal Antibodies Product Specifications
1.3 Main Events (Entry, M&A, Exit, Technology and Capital Activity)
1.4 Global Biosimilar Monoclonal Antibodies Market Performance and Outlook

2 Market Development Performance under COVID-19
2.1 Influencing Factors of Industry Development in the Next Five Years
2.1.1 Drivers
2.1.2 Restraints
2.1.3 Opportunities
2.2 Porter’s Five Forces Analysis
2.3 Comparison of Alternatives and Biosimilar Monoclonal Antibodies

3 Supply Chain and Manufacturing Cost Analysis
3.1 Supply Chain Analysis
3.2 Raw Materials and Key Suppliers Analysis
3.2.1 Raw Materials Introduction
3.2.1 Raw Materials Key Suppliers List
3.3 Biosimilar Monoclonal Antibodies Sales Channel and Distributors Analysis
3.3.1 Biosimilar Monoclonal Antibodies Sales Channel
3.3.2 Biosimilar Monoclonal Antibodies Distributors
3.4 Key Buying Industries/Consumers
3.4.1 Major Buyers in Oncology
3.4.2 Major Buyers in Autoimmune Disease
3.5 Biosimilar Monoclonal Antibodies Manufacturing Cost Structure Analysis

4 Market Segment: by Type
4.1 Biosimilar Monoclonal Antibodies Type Introduction
4.1.1 Infliximab
4.1.2 Rituximab
4.1.3 Trastuzumab
4.1.4 Adalimumab
4.1.5 Other
4.2 Global Biosimilar Monoclonal Antibodies Sales by Type 2016-2021
4.3 Global Biosimilar Monoclonal Antibodies Revenue by Type 2016-2021
4.4 Global Biosimilar Monoclonal Antibodies Price by Type 2016-2021

5 Market Segment: by Application
5.1 Biosimilar Monoclonal Antibodies Type Introduction
5.1.1 Oncology
5.1.2 Autoimmune Disease
5.1.3 Other
5.2 Global Biosimilar Monoclonal Antibodies Sales by Application 2016-2021
5.3 Global Biosimilar Monoclonal Antibodies Revenue by Application 2016-2021
5.4 Global Biosimilar Monoclonal Antibodies Price by Application 2016-2021

6 Marke Segment: by Region
6.1 Global Biosimilar Monoclonal Antibodies Market by Region
6.1.1 Global Biosimilar Monoclonal Antibodies Sales by Regions
6.1.2 Global Biosimilar Monoclonal Antibodies Revenue by Regions
6.2 North America Biosimilar Monoclonal Antibodies Market 2016-2021
6.3 Europe Biosimilar Monoclonal Antibodies Market 2016-2021
6.4 Asia Pacific Biosimilar Monoclonal Antibodies Market 2016-2021
6.5 South America Biosimilar Monoclonal Antibodies Market 2016-2021
6.6 Middle East and Africa Biosimilar Monoclonal Antibodies Market 2016-2021

7 North America
7.1 North America Biosimilar Monoclonal Antibodies Market by Country 2016-2021
7.1.1 North America Biosimilar Monoclonal Antibodies Sales by Country
7.1.2 North America Biosimilar Monoclonal Antibodies Revenue by Country
7.2 United States
7.3 Canada
7.4 Mexico

8 Europe
8.1 Europe Biosimilar Monoclonal Antibodies Market by Country 2016-2021
8.1.1 Europe Biosimilar Monoclonal Antibodies Sales by Country
8.1.2 Europe Biosimilar Monoclonal Antibodies Revenue by Country
8.2 Germany
8.3 France
8.4 UK
8.5 Italy
8.6 Russia
8.7 Spain

9 Asia Pacific
9.1 Asia Pacific Biosimilar Monoclonal Antibodies Market by Country 2016-2021
9.1.1 Asia Pacific Biosimilar Monoclonal Antibodies Sales by Country
9.1.2 Asia Pacific Biosimilar Monoclonal Antibodies Revenue by Country
9.2 China
9.3 Japan
9.4 Korea
9.5 Southeast Asia
9.6 India
9.7 Australia

10 South America
10.1 South America Biosimilar Monoclonal Antibodies Market by Country 2016-2021
10.1.1 South America Biosimilar Monoclonal Antibodies Sales by Country
10.1.2 South America Biosimilar Monoclonal Antibodies Revenue by Country
10.2 Brazil
10.3 Argentina
10.4 Colombia

11 Middle East and Africa
11.1 Middle East and Africa Biosimilar Monoclonal Antibodies Market by Country 2016-2021
11.1.1 Middle East and Africa Biosimilar Monoclonal Antibodies Sales by Country
11.1.2 Middle East and Africa Biosimilar Monoclonal Antibodies Revenue by Country
11.2 Turkey
11.3 Saudi Arabia
11.4 South Africa

12 Key Participants Company Information
12.1 Torrent Pharmaceuticals
12.1.1 Torrent Pharmaceuticals Company Information
12.1.2 Torrent Pharmaceuticals Biosimilar Monoclonal Antibodies Product Portfolio, Specification and Application
12.1.3 Torrent Pharmaceuticals Biosimilar Monoclonal Antibodies Sales, Price, Revenue and Gross Margin (2019-2021)
12.1.4 Torrent Pharmaceuticals Key Development
12.2 Pfizer (Hospira)
12.2.1 Pfizer (Hospira) Company Information
12.2.2 Pfizer (Hospira) Biosimilar Monoclonal Antibodies Product Portfolio, Specification and Application
12.2.3 Pfizer (Hospira) Biosimilar Monoclonal Antibodies Sales, Price, Revenue and Gross Margin (2019-2021)
12.2.4 Pfizer (Hospira) Key Development
12.3 Novartis (Sandoz)
12.3.1 Novartis (Sandoz) Company Information
12.3.2 Novartis (Sandoz) Biosimilar Monoclonal Antibodies Product Portfolio, Specification and Application
12.3.3 Novartis (Sandoz) Biosimilar Monoclonal Antibodies Sales, Price, Revenue and Gross Margin (2019-2021)
12.3.4 Novartis (Sandoz) Key Development
12.4 Hisun Pharma
12.4.1 Hisun Pharma Company Information
12.4.2 Hisun Pharma Biosimilar Monoclonal Antibodies Product Portfolio, Specification and Application
12.4.3 Hisun Pharma Biosimilar Monoclonal Antibodies Sales, Price, Revenue and Gross Margin (2019-2021)
12.4.4 Hisun Pharma Key Development
12.5 Dr Reddy’s
12.5.1 Dr Reddy’s Company Information
12.5.2 Dr Reddy’s Biosimilar Monoclonal Antibodies Product Portfolio, Specification and Application
12.5.3 Dr Reddy’s Biosimilar Monoclonal Antibodies Sales, Price, Revenue and Gross Margin (2019-2021)
12.5.4 Dr Reddy’s Key Development
12.6 Celltrion
12.6.1 Celltrion Company Information
12.6.2 Celltrion Biosimilar Monoclonal Antibodies Product Portfolio, Specification and Application
12.6.3 Celltrion Biosimilar Monoclonal Antibodies Sales, Price, Revenue and Gross Margin (2019-2021)
12.6.4 Celltrion Key Development
12.7 Celgen Biopharma
12.7.1 Celgen Biopharma Company Information
12.7.2 Celgen Biopharma Biosimilar Monoclonal Antibodies Product Portfolio, Specification and Application
12.7.3 Celgen Biopharma Biosimilar Monoclonal Antibodies Sales, Price, Revenue and Gross Margin (2019-2021)
12.7.4 Celltrion Key Development
12.9 3SBIO
12.9.1 3SBIO Company Information
12.9.2 3SBIO Biosimilar Monoclonal Antibodies Product Portfolio, Specification and Application
12.9.3 3SBIO Biosimilar Monoclonal Antibodies Sales, Price, Revenue and Gross Margin (2019-2021)
12.9.4 3SBIO Key Development
12.8.1 Cadila Healthcare Company Information
12.8.2 Cadila Healthcare Biosimilar Monoclonal Antibodies Product Portfolio, Specification and Application
12.8.3 Cadila Healthcare Biosimilar Monoclonal Antibodies Sales, Price, Revenue and Gross Margin (2019-2021)
12.8.4 Cadila Healthcare Key Development

13 Global Biosimilar Monoclonal Antibodies Market Forecast by Region by Type and by Application
13.1 Global Biosimilar Monoclonal Antibodies Sales, Revenue Forecast 2022-2027
13.2 Global Biosimilar Monoclonal Antibodies Forecast by Regions
13.2.1 Global Biosimilar Monoclonal Antibodies Sales Forecast by Region 2022-2027
13.2.2 Global Biosimilar Monoclonal Antibodies Revenue Forecast by Region 2022-2027
13.3 Global Biosimilar Monoclonal Antibodies Forecast by Type
13.3.1 Global Biosimilar Monoclonal Antibodies Sales Forecast by Type 2022-2027
13.3.2 Global Biosimilar Monoclonal Antibodies Revenue Forecast by Type 2022-2027
13.3.3 Global Biosimilar Monoclonal Antibodies Price Forecast by Type 2022-2027
13.4 Global Biosimilar Monoclonal Antibodies Forecast by Application
13.4.1 Global Biosimilar Monoclonal Antibodies Sales Forecast by Application 2022-2027
13.4.2 Global Biosimilar Monoclonal Antibodies Revenue Forecast by Application 2022-2027
13.4.3 Global Biosimilar Monoclonal Antibodies Price Forecast by Application 2022-2027

14 Analyst Views and Conclusions

15 Methodology and Data Source
15.1 Methodology
15.2 Research Data Source
15.2.1 Secondary Data
15.2.2 Primary Data
15.2.3 Market Size Estimation
15.3 Legal Disclaimer

List of Figure

List of Tables

Table 1: Global Biosimilar Monoclonal Antibodies Production Specifications
Table 2: Drivers in Biosimilar Monoclonal Antibodies Market
Table 3: Restraints Biosimilar Monoclonal Antibodies Market
Table 4: Opportunity in Biosimilar Monoclonal Antibodies Market
Table 5: Comparion of Alternative and Biosimilar Monoclonal Antibodies
Table 6: Biosimilar Monoclonal Antibodies Raw Materials Key Suppliers List
Table 7: Biosimilar Monoclonal Antibodies Distributors List
Table 8: Biosimilar Monoclonal Antibodies Major Buyers in Oncology
Table 9: Biosimilar Monoclonal Antibodies Major Buyers in Autoimmune Disease
Table 10: Biosimilar Monoclonal Antibodies Major Buyers in Other
Table 11: Global Biosimilar Monoclonal Antibodies Sales (K Units) by Type 2016-2021
Table 12: Global Biosimilar Monoclonal Antibodies Sales Market Share by Type 2016-2021
Table 13: Global Biosimilar Monoclonal Antibodies Revenue (Million USD) by Type 2016-2021
Table 14: Global Biosimilar Monoclonal Antibodies Revenue Market Share by Type 2016-2021
Table 15: Global Biosimilar Monoclonal Antibodies Price by Type 2016-2021
Table 16: Global Biosimilar Monoclonal Antibodies Sales (K Units) by Application 2016-2021
Table 17: Global Biosimilar Monoclonal Antibodies Sales Market Share by Application 2016-2021
Table 18: Global Biosimilar Monoclonal Antibodies Revenue (Million USD) by Application 2016-2021
Table 19: Global Biosimilar Monoclonal Antibodies Revenue Market Share by Application 2016-2021
Table 20: Global Biosimilar Monoclonal Antibodies Price by Application 2016-2021
Table 21: Global Biosimilar Monoclonal Antibodies Sales (K Units) by Region 2016-2021
Table 22: Global Biosimilar Monoclonal Antibodies Sales Market Share by Region 2016-2021
Table 23: Global Biosimilar Monoclonal Antibodies Revenue (Million USD) by Region 2016-2021
Table 24: Global Biosimilar Monoclonal Antibodies Revenue Market Share by Region 2016-2021
Table 25: North America Biosimilar Monoclonal Antibodies Sales (K Units) by Country 2016-2021
Table 26: North America Biosimilar Monoclonal Antibodies Sales Market Share by Country 2016-2021
Table 27: North America Biosimilar Monoclonal Antibodies Revenue (Million USD) by Country 2016-2021
Table 28: North America Biosimilar Monoclonal Antibodies Revenue Market Share by Country 2016-2021)
Table 29: Europe Biosimilar Monoclonal Antibodies Sales (K Units) by Country 2016-2021
Table 30: Europe Biosimilar Monoclonal Antibodies Sales Market Share by Country 2016-2021
Table 31: Europe Biosimilar Monoclonal Antibodies Revenue (Million USD) by Country 2016-2021
Table 32: Europe Biosimilar Monoclonal Antibodies Revenue Market Share by Country 2016-2021)
Table 33: Asia Pacific Biosimilar Monoclonal Antibodies Sales (K Units) by Country 2016-2021
Table 34: Asia Pacific Biosimilar Monoclonal Antibodies Sales Market Share by Country 2016-2021
Table 35: Asia Pacific Biosimilar Monoclonal Antibodies Revenue (Million USD) by Country 2016-2021
Table 36: Asia Pacific Biosimilar Monoclonal Antibodies Revenue Market Share by Country 2016-2021)
Table 37: South America Biosimilar Monoclonal Antibodies Sales (K Units) by Country 2016-2021
Table 38: South America Biosimilar Monoclonal Antibodies Sales Market Share by Country 2016-2021
Table 39: South America Biosimilar Monoclonal Antibodies Revenue (Million USD) by Country 2016-2021
Table 40: South America Biosimilar Monoclonal Antibodies Revenue Market Share by Country 2016-2021)
Table 41: Middle East and Africa Biosimilar Monoclonal Antibodies Sales (K Units) by Country 2016-2021
Table 42: Middle East and Africa Biosimilar Monoclonal Antibodies Sales Market Share by Country 2016-2021
Table 43: Middle East and Africa Biosimilar Monoclonal Antibodies Revenue (Million USD) by Country 2016-2021
Table 44: Middle East and Africa Biosimilar Monoclonal Antibodies Revenue Market Share by Country 2016-2021)
Table 45 Torrent Pharmaceuticals Company Information
Table 46 Torrent Pharmaceuticals Biosimilar Monoclonal Antibodies Product Portfolio, Specification and Application
Table 47 Torrent Pharmaceuticals Biosimilar Monoclonal Antibodies Sales, Price, Revenue and Gross Margin (2019-2021)
Table 48 Pfizer (Hospira) Company Information
Table 49 Pfizer (Hospira) Biosimilar Monoclonal Antibodies Product Portfolio, Specification and Application
Table 50 Pfizer (Hospira) Biosimilar Monoclonal Antibodies Sales, Price, Revenue and Gross Margin (2019-2021)
Table 51 Novartis (Sandoz) Company Information
Table 52 Novartis (Sandoz) Biosimilar Monoclonal Antibodies Product Portfolio, Specification and Application
Table 53 Novartis (Sandoz) Biosimilar Monoclonal Antibodies Sales, Price, Revenue and Gross Margin (2019-2021)
Table 54 Hisun Pharma Company Information
Table 55 Hisun Pharma Biosimilar Monoclonal Antibodies Product Portfolio, Specification and Application
Table 56 Hisun Pharma Biosimilar Monoclonal Antibodies Sales, Price, Revenue and Gross Margin (2019-2021)
Table 57 Dr Reddy’s Company Information
Table 58 Dr Reddy’s Biosimilar Monoclonal Antibodies Product Portfolio, Specification and Application
Table 59 Dr Reddy’s Biosimilar Monoclonal Antibodies Sales, Price, Revenue and Gross Margin (2019-2021)
Table 60 Celltrion Company Information
Table 61 Celltrion Biosimilar Monoclonal Antibodies Product Portfolio, Specification and Application
Table 62 Celltrion Biosimilar Monoclonal Antibodies Sales, Price, Revenue and Gross Margin (2019-2021)
Table 63 Celgen Biopharma Company Information
Table 64 Celgen Biopharma Biosimilar Monoclonal Antibodies Product Portfolio, Specification and Application
Table 65 Celgen Biopharma Biosimilar Monoclonal Antibodies Sales, Price, Revenue and Gross Margin (2019-2021)
Table 66 Cadila Healthcare Company Information
Table 67 Cadila Healthcare Biosimilar Monoclonal Antibodies Product Portfolio, Specification and Application
Table 68 Cadila Healthcare Biosimilar Monoclonal Antibodies Sales, Price, Revenue and Gross Margin (2019-2021)
Table 69 3SBIO Company Information
Table 70 3SBIO Biosimilar Monoclonal Antibodies Product Portfolio, Specification and Application
Table 71 3SBIO Biosimilar Monoclonal Antibodies Sales, Price, Revenue and Gross Margin (2019-2021)
Table 72: Global Biosimilar Monoclonal Antibodies Sales (K Units) Forecast by Region (2022-2027)
Table 73: Global Biosimilar Monoclonal Antibodies Sales Market Share Forecast by Region (2012-2027)
Table 74: Global Biosimilar Monoclonal Antibodies Revenue (Million USD) Forecast by Region (2022-2027)
Table 75: Global Biosimilar Monoclonal Antibodies Revenue Market Share Forecast by Region (2022-2027)
Table 76: Global Biosimilar Monoclonal Antibodies Sales (K Units) Forecast by Type (2022-2027)
Table 77: Global Biosimilar Monoclonal Antibodies Sales Market Share Forecast by Type (2012-2027)
Table 78: Global Biosimilar Monoclonal Antibodies Revenue (Million USD) Forecast by Type (2022-2027)
Table 79: Global Biosimilar Monoclonal Antibodies Revenue Market Share Forecast by Type (2022-2027)
Table 80: Global Biosimilar Monoclonal Antibodies Sales (K Units) Forecast by Applicaion (2022-2027)
Table 81: Global Biosimilar Monoclonal Antibodies Sales Market Share Forecast by Application (2012-2027)
Table 82: Global Biosimilar Monoclonal Antibodies Revenue (Million USD) Forecast by Application (2022-2027)
Table 83: Global Biosimilar Monoclonal Antibodies Revenue Market Share Forecast by Application (2022-2027)


List of Figures

Figure 1: Biosimilar Monoclonal Antibodies Picture
Figure 2: Global Biosimilar Monoclonal Antibodies Market Size (Million USD) and Growth Rate (2016-2027)
Figure 3: Porter's Five Forces Analysis
Figure 4: Biosimilar Monoclonal Antibodies Supply Chain Analysis
Figure 5: Biosimilar Monoclonal Antibodies Manufacturing Cost Structure Analysis
Figure 6: Product Picture of Infliximab
Figure 7: Product Picture of Rituximab
Figure 8: Global Biosimilar Monoclonal Antibodies Sales Market Share by Type, 2020
Figure 9: Global Biosimilar Monoclonal Antibodies Revenue Market Share by Type, 2020
Figure 10: Biosimilar Monoclonal Antibodies in Oncology
Figure 11: Global Biosimilar Monoclonal Antibodies Market: Oncology 2016-2021
Figure 12: Biosimilar Monoclonal Antibodies in Autoimmune Disease
Figure 13: Global Biosimilar Monoclonal Antibodies Market: Autoimmune Disease 2016-2021
Figure 14: Global Biosimilar Monoclonal Antibodies Sales Market Share by Application, 2020
Figure 15: Global Biosimilar Monoclonal Antibodies Revenue Market Share by Application, 2020
Figure 16: Global Biosimilar Monoclonal Antibodies Sales Market Share by Region 2016-2021
Figure 17: Global Biosimilar Monoclonal Antibodies Revenue Market Share by Region 2016-2021
Figure 18: North America Biosimilar Monoclonal Antibodies Sales (K Units) Status 2016-2021
Figure 19: North America Biosimilar Monoclonal Antibodies Revenue (Million USD) Status 2016-2021
Figure 20: Europe Biosimilar Monoclonal Antibodies Sales (K Units) Status 2016-2021
Figure 21: Europe Biosimilar Monoclonal Antibodies Revenue (Million USD) Status 2016-2021
Figure 22: Asia Pacific Biosimilar Monoclonal Antibodies Sales (K Units) Status 2016-2021
Figure 23: Asia Pacific Biosimilar Monoclonal Antibodies Revenue (Million USD) Status 2016-2021
Figure 24: South America Biosimilar Monoclonal Antibodies Sales (K Units) Status 2016-2021
Figure 25: South America Biosimilar Monoclonal Antibodies Revenue (Million USD) Status 2016-2021
Figure 26: Middle East and Africa Biosimilar Monoclonal Antibodies Sales (K Units) Status 2016-2021
Figure 27: Middle East and Africa Biosimilar Monoclonal Antibodies Revenue (Million USD) Status 2016-2021
Figure 28: North America Biosimilar Monoclonal Antibodies Sales Market Share by Country, 2020
Figure 29: North America Biosimilar Monoclonal Antibodies Revenue Market Share by Country, 2020
Figure 30: United States Biosimilar Monoclonal Antibodies Sales (K Units) Status 2016-2021
Figure 31: United States Biosimilar Monoclonal Antibodies Revenue (Million USD) Status 2016-2021
Figure 32: Canada Biosimilar Monoclonal Antibodies Sales (K Units) Status 2016-2021
Figure 33: Canada Biosimilar Monoclonal Antibodies Revenue (Million USD) Status 2016-2021
Figure 34: Mexico Biosimilar Monoclonal Antibodies Sales (K Units) Status 2016-2021
Figure 35: Mexico Biosimilar Monoclonal Antibodies Revenue (Million USD) Status 2016-2021
Figure 36: Europe Biosimilar Monoclonal Antibodies Sales Market Share by Country, 2020
Figure 37: Europe Biosimilar Monoclonal Antibodies Revenue Market Share by Country, 2020
Figure 38: Germany Biosimilar Monoclonal Antibodies Sales (K Units) Status 2016-2021
Figure 39: Germany Biosimilar Monoclonal Antibodies Revenue (Million USD) Status 2016-2021
Figure 40: France Biosimilar Monoclonal Antibodies Sales (K Units) Status 2016-2021
Figure 41: France Biosimilar Monoclonal Antibodies Revenue (Million USD) Status 2016-2021
Figure 42: UK Biosimilar Monoclonal Antibodies Sales (K Units) Status 2016-2021
Figure 43: UK Biosimilar Monoclonal Antibodies Revenue (Million USD) Status 2016-2021
Figure 44: Italy Biosimilar Monoclonal Antibodies Sales (K Units) Status 2016-2021
Figure 45: Italy Biosimilar Monoclonal Antibodies Revenue (Million USD) Status 2016-2021
Figure 46: Russia Biosimilar Monoclonal Antibodies Sales (K Units) Status 2016-2021
Figure 46: Russia Biosimilar Monoclonal Antibodies Revenue (Million USD) Status 2016-2021
Figure 47: Spain Biosimilar Monoclonal Antibodies Sales (K Units) Status 2016-2021
Figure 48: Spain Biosimilar Monoclonal Antibodies Revenue (Million USD) Status 2016-2021
Figure 49: Asia Pacific Biosimilar Monoclonal Antibodies Sales Market Share by Country, 2020
Figure 50: Asia Pacific Biosimilar Monoclonal Antibodies Revenue Market Share by Country, 2020
Figure 51: China Biosimilar Monoclonal Antibodies Sales (K Units) Status 2016-2021
Figure 52: China Biosimilar Monoclonal Antibodies Revenue (Million USD) Status 2016-2021
Figure 53: Japan Biosimilar Monoclonal Antibodies Sales (K Units) Status 2016-2021
Figure 54: Japan Biosimilar Monoclonal Antibodies Revenue (Million USD) Status 2016-2021
Figure 55: Korea Biosimilar Monoclonal Antibodies Sales (K Units) Status 2016-2021
Figure 56: Korea Biosimilar Monoclonal Antibodies Revenue (Million USD) Status 2016-2021
Figure 57: Southeast Asia Biosimilar Monoclonal Antibodies Sales (K Units) Status 2016-2021
Figure 58: Southeast Asia Biosimilar Monoclonal Antibodies Revenue (Million USD) Status 2016-2021
Figure 59: India Biosimilar Monoclonal Antibodies Sales (K Units) Status 2016-2021
Figure 60: India Biosimilar Monoclonal Antibodies Revenue (Million USD) Status 2016-2021
Figure 61: Australia Biosimilar Monoclonal Antibodies Sales (K Units) Status 2016-2021
Figure 62: Australia Biosimilar Monoclonal Antibodies Revenue (Million USD) Status 2016-2021
Figure 63: South America Biosimilar Monoclonal Antibodies Sales Market Share by Country, 2020
Figure 64: South America Biosimilar Monoclonal Antibodies Revenue Market Share by Country, 2020
Figure 65: Brazil Biosimilar Monoclonal Antibodies Sales (K Units) Status 2016-2021
Figure 66: Brazil Biosimilar Monoclonal Antibodies Revenue (Million USD) Status 2016-2021
Figure 67: Argentina Biosimilar Monoclonal Antibodies Sales (K Units) Status 2016-2021
Figure 68: Argentina Biosimilar Monoclonal Antibodies Revenue (Million USD) Status 2016-2021
Figure 69: Colombia Biosimilar Monoclonal Antibodies Sales (K Units) Status 2016-2021
Figure 70: Colombia Biosimilar Monoclonal Antibodies Revenue (Million USD) Status 2016-2021
Figure 71: Middle East and Africa Biosimilar Monoclonal Antibodies Sales Market Share by Country, 2020
Figure 72: Middle East and Africa Biosimilar Monoclonal Antibodies Revenue Market Share by Country, 2020
Figure 73: Turkey Biosimilar Monoclonal Antibodies Sales (K Units) Status 2016-2021
Figure 74: Turkey Biosimilar Monoclonal Antibodies Revenue (Million USD) Status 2016-2021
Figure 75: Saudi Arabia Biosimilar Monoclonal Antibodies Sales (K Units) Status 2016-2021
Figure 76: Saudi Arabia Biosimilar Monoclonal Antibodies Revenue (Million USD) Status 2016-2021
Figure 77: South Africa Biosimilar Monoclonal Antibodies Sales (K Units) Status 2016-2021
Figure 78: South Africa Biosimilar Monoclonal Antibodies Revenue (Million USD) Status 2016-2021
Figure 79: Torrent Pharmaceuticals Biosimilar Monoclonal Antibodies Revenue Market Share Globally (2019-2021)
Figure 80: Pfizer (Hospira) Biosimilar Monoclonal Antibodies Revenue Market Share Globally (2019-2021)
Figure 81: Novartis (Sandoz) Biosimilar Monoclonal Antibodies Revenue Market Share Globally (2019-2021)
Figure 82: Hisun Pharma Biosimilar Monoclonal Antibodies Revenue Market Share Globally (2019-2021)
Figure 83: Dr Reddy’s Biosimilar Monoclonal Antibodies Revenue Market Share Globally (2019-2021)
Figure 84: Celltrion Biosimilar Monoclonal Antibodies Revenue Market Share Globally (2019-2021)
Figure 85: Celgen Biopharma Biosimilar Monoclonal Antibodies Revenue Market Share Globally (2019-2021)
Figure 86: Cadila Healthcare Biosimilar Monoclonal Antibodies Revenue Market Share Globally (2019-2021)
Figure 87: 3SBIO Biosimilar Monoclonal Antibodies Revenue Market Share Globally (2019-2021)
Figure 89: Global Biosimilar Monoclonal Antibodies Sales (K Units) Forecast (2022-2027)
Figure 90: Global Biosimilar Monoclonal Antibodies Sales (K Units) Forecast (2022-2027)

Select User License

$3980 Single Licence
$5950 Enterprise Licence
$7960 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries